The oral drug is an alternative to the infused enzyme replacement therapy that is current standard of care - Sanofi/Genzyme’s Fabarazyme (agalsidase beta). Already approved in Europe ...

PranaX Corporation, a pioneer in exosome-based regenerative wellness, has appointed Phillip Maderia as its new Chief ...

Do you want to know how you can develop new drugs to combat drug-resistant microorganisms? How to find a way to imprint the immune system to increase tolerance? Reducing the side effects of treatment ...